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A SURVEY OF UK HEALTH CARE WORKERS’ VIEWS ON THE
USE OF HANDHELD COMPUTERS IN EVIDENCE-BASED
CLINICAL PRACTICE
Dickson AJ1, Strayer SM2
1University of Newcastle-upon-Tyne, Newcastle-upon-Tyne, UK,
2University of Virginia, Charlottesville,VA, USA
Handheld computers are increasingly being advocated for use in
clinical medicine. Current proﬁciency of computers appears low
and patchy within NHS hospitals. A literature search using
PubMed found few papers focussing on the use of handhelds in
clinical practice. OBJECTIVE: To conduct an exploratory, obser-
vational survey on the views of two convenience samples of users
and prospective users of handheld computers. METHODS: A
pilot survey of practicing health care workers in the UK was con-
ducted at 2 national conferences on evidence-based medicine.
Respondents’ views were elicited with regard to the extent that
they agree or disagree with a series of statements on: how hand-
held computers assist them in their clinical practice; the barriers
to using handheld computers in clinical practice. RESULTS:
Eleven completed questionnaires were returned: response rate of
approximately 10%. The results indicate there is a lot of uncer-
tainty about the beneﬁts of handheld computers and the barri-
ers to using them. It appears clear that handheld computers
improve the respondents’ efﬁciency, whilst the main barrier to
use is lack of technical support. The respondents do not feel that
patient perception is a barrier to using handheld computers by
health care professionals. CONCLUSION: This pilot survey
indicates that the modiﬁed US questionnaire can be applied to
the UK. The results indicate that another survey, if adequately
powered and sufﬁciently representative, would be useful in
helping identify areas of concern in the use of handhelds by UK
health care professionals.
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ANTIBIOTIC UTILIZATION IN NIS REGION OF SERBIA AND
MONTENEGRO
Kodela B1,Velickovic-Radovanovic R2, Lilic R2, Petrovic J2
1Pharmacy Institution, Nis, Serbia, Serbia and Montenegro, 2Clinical
Centre, Nis, Serbia, Serbia and Montenegro
OBJECTIVES: Pharmacoeconomic analyses present the basis for
the evaluation of therapy rationalization within a certain popu-
lation. Antibiotics are among the most often prescribed medica-
tions in primary health care. In total expenditure, antibiotics
amount to 16, 15% of the total health care budget on the terri-
tory of Nis. The aim of our work was to monitor and analyze
the out-patient usage of antibiotics in Nis area, in the period of
2003 to 2005. METHODS: By using the ATC/DDD methodol-
ogy, we analyzed the expenditure of the antibiotics and presented
the results as the deﬁned daily doses (DDD) for 1000 citizens per
day. RESULTS: The total usage of antibiotics increased in 2005
(22.83:25.96 DDD/1000/a day, p < 0.05). The most frequently
prescribed antibiotics are half-synthetic penicillins (9.67:10.0
DDD/1000/a day), then follow macrolides with a signiﬁcant ten-
dency of growth (3.05:4.9 DDD/1000/a day, p < 0.05). The
biggest growth has been registered with the usage of azitromycin
(0.26:0.7 DDD/1000/day), the number of prescribed recipes
shows the growth of 164%. The usage of antibiotics shows the
growth of 14% in the year 2005 regarding 2003. By analyzing
the number of prescribed recipes, the growth of 3, 2% in the
prescribing of the antibiotics has been registered. It is important
to point out that all prescribed antibiotics were on the positive
drug list. CONCLUSIONS: This analyzes showed an irrational
usage of the antibiotics in primary health care in Nis area, which
requires additional application of educative programs. The cited
results will be basis for further evaluations of the rationality in
the usage of antibiotics in primary health care.
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USE OF ANTIBIOTICS AT CLINICAL CENTRE 
OF MONTENEGRO
Goranovic S
University of Montenegro, Podgorica, Serbia and Montenegro
OBJECTIVES: The main aim of inpatient drug utilization studies
is to promote the rational use of drugs. Those studies provide
useful informations about doctors’ prescribing habits and possi-
ble goals for improvement of pharmacotherapy and pharma-
coeconomics. The aim of our study was to analyze the use of
antibiotics at four surgical departments of Clinical Center of
Montenegro (Plastic Surgery Clinic, Orthopedics and Trauma
Center, Abdominal Clinic and Urology Clinic), to compare
obtained data with appropriate data in developed countries and
with recent pharmacotherapeutic guidelines. METHODS: We
used Central Pharmacy report as the source of data about drugs
delivered to surgical departments in period of three months.
According to internationally accepted methodology, inpatient
drug utilization was expressed as number of deﬁned daily
doses/1000 bed days (DDD/1000 BD). Drugs were sorted by
ATC classiﬁcation. RESULTS: In observed period 999 patients
were hospitalized and 9604 bed days were realized at four sur-
gical departments. Average duration of hospitalization was 9.6
days. Total usage of general anti-infectives (ATC group J) was,
in average, 1206.9 DDD/1000 BD, which means that every
patient got one DDD per day. The most frequent utilization was
at Abdominal Surgery Clinic. The most frequently used were
cephalosporins with 580 DDD/1000 BD (40%). Aminoglyco-
sides were on the second place with 376 DDD/1000 BD (31%).
The third place pertained to penicillin’s with 119 DDD/1000 BD
(10%). Ceftriaxon was the most often used antibacterial drug
during investigated period (425.4 DDD/1000 BD). CONCLU-
SIONS: Drug utilization at four Surgery Clinics in most cases
was in accordance with recent pharmacotherapeutic guidelines.
Noticed differences suggest that we need to afﬁrm better
approach when selecting appropriate pharmacotherapy, which
will certainly have a pharmacoeconomic consequences.
PHP10
POTENTIAL IMPACT OF HOSPITAL DISCHARGE
PRESCRIPTIONS ON COMMUNITY PRESCRIBING—AN IRISH
PERSPECTIVE
Usher C,Tilson L, Barry M
National Centre for Pharmacoeconomics, Dublin 8, Ireland
OBJECTIVE: In Ireland hospital prescribing is thought to 
inﬂuence general practitioner (GP) prescribing and GPs have
expressed concern over recommendations originating from sec-
ondary care, particularly in relation to the impact on drug expen-
diture. The aim of this study was to examine the range of proton
pump inhibitors (PPIs) prescribed to patients at hospital dis-
charge (generic vs proprietary) and on follow-up in the commu-
nity. METHODS: A national primary care prescription database
(covering approximately 1.15 million persons) was used to iden-
tify patients (n = 10,792) who received a hospital discharge pre-
scription for a PPI (ATC code: A02BC) from July-December
2004 and were followed up for 3 months post discharge.
RESULTS: Approximately 37.3% of patients discharged from
hospital were prescribed lansoprazole (total ingredient cost =
€48,691); 21.6% were prescribed esomeprazole (ingredient 
cost = €28,862); 21.4% were prescribed omeprazole (17.9%
branded, ingredient cost = €37,764 and 3.5% generic, ingredi-
ent cost = €4748); 16.6% were prescribed pantoprazole (ingre-
dient cost = €18612) and 3.1% were prescribed rabeprazole
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(ingredient cost = €3243). Potential savings if the cheapest
generic omeprazole equivalent were dispensed (instead of pro-
prietary omeprazole) would be approximately 6.2% of the total
hospital expenditure on PPIs for the period examined. When
follow-up prescriptions in the community were examined
approximately 60% of patients did not receive further PPI med-
ication. Of those who continued to receive a prescription for a
PPI, approximately 30% remained on the PPI prescribed in hos-
pital. CONCLUSIONS: Considering that generic omeprazole
has the same therapeutic indications as proprietary omeprazole,
there exists a case for more generic PPI utilisation in Irish hos-
pitals. However, the fact that lansoprazole is priced comparably
to generic omeprazole is encouraging. Regarding follow-up PPI
prescribing in the community, it appears that where follow-up
prescriptions are issued, GPs are more likely to reproduce the
hospital prescription, rather than switch to an alternative PPI.
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DOSE DISPENSED MEDICINE AND ASSOCIATED MEDICINE
AND HEALTH CARE COST
Søndergaard B1, Gundgaard J2, Sørensen J3, Hansen EH1
1Danish University of Pharmaceutical Sciences, Copenhagen,
Denmark, 2University of Southern Denmark, Odense C, Denmark,
3Centre for Applied Health Services Research and Technology
Assessment, Odense C, Denmark
OBJECTIVE: In 2001 a new law was passed to allow Danish
pharmacies to distribute dose dispensed medicine (DDM).
Studies have shown that DDM can reduce medicine costs. Other
studies have evaluated patient satisfaction and compliance. 
No studies have evaluated the health effects of DDM. The objec-
tive of this study was to describe the development in medicine
costs; contacts to GPs; and hospital costs before and after start-
ing on DDM. METHODS: National register analysis of patients
receiving DDM from 2001 to 2004 (n = 19,004). The data set
included medicine use and costs (Danish Medicine Register), hos-
pital admissions (Danish Patient Register), health care contacts
and costs (Health Insurance Register). The analysis covers data
from six months before and after ﬁrst day of DDM. RESULTS:
3.464 patients are included in the 2003 analysis and 4.491 in the
2004 analysis. On average patients used 5.3 DDM and 1.1 med-
icines that could not be dose-dispensed. Approx. 25% of the
total medicine costs were due to dispensing fees. The proportion
of patients with GP contacts decreased (from 0.75 per month to
0.57). The average cost per patient on a semi-annual basis was
115.0 Euro before and 99.7 Euro after (2003 data). The pro-
portion of patients hospitalised decreased from 0.06 per months
before to 0.04 per months after (2003 data) and from 0.07 to
0.04 per months (2004 data). The average cost per patient on a
semi-annual basis was 1445.0 Euro before and 882.0 Euro after
(2003 data). The mean length of stay decreased (from 9 to 6
days) as well as the total number of hospital-days (from 15.397
to 5.909) (2004 data). CONCLUSION: The introduction of
DDM resulted in an increase in medicine costs and a decrease in
health care costs. Both the proportion of patients hospitalised
and the length of stay in hospital decreased.
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WASTAGE OF MEDICINES IN PORTUGAL
Crisóstomo S1, Mendes Z1, Batel Marques F2, Martins P1,
Rodrigues V3, Fontes Ribeiro C3
1Centre for Pharmacoepidemiologic Research, National Association of
Pharmacies, Lisboa, Portugal, 2Centre for Health Studies and
Research, School of Economics and School of Pharmacy—University
of Coimbra, Coimbra, Portugal, 3School of Medicine—University of
Coimbra, Coimbra, Portugal
OBJECTIVES: Medicines waste, with both public health and
economic impact, has been identiﬁed as a problem within the
Portuguese National Health Service (PNHS). This provided the
rational to identify the extent of medicines wastage due to inad-
equacy of medicines pack sizes to the proposed treatments length
and to further estimate non-used medicines due to patients’ non-
adherence, regardless of packs inadequacy. METHODS: A phar-
macy-based prospective two phase study was carried out. New
medication users were invited to participate. Prescribed pack
sizes were scrutinized to evaluate the extent in which they
matched treatment lengths. First-phase study enrollees were
further invited to participate in a telephone interview for pill
counting at the end of the prescribed treatment period (second
phase of the study). RESULTS: From September 2005 to March
2006, 1501 patients were included in the study ﬁrst phase (mean
age 50.1, 68.6% females). A total of 2098 medicines were dis-
pensed to these patients. The cost of wastage associated with
medicines pack sizes was on average 1.75 € [95% CI: 1.51
€–2.00 €] with 58.5% being charged to the PNHS. This cost was
higher than 4.00 € for anti-inﬂammatory and antirheumatic
products, drugs for acid related disorders, corticosteroids for 
systemic use, drugs for obstructive airway diseases, and anti-
protozoals. However the wastage cost represented more than
25% of total expenditure only for anti-inﬂammatory and
antirheumatic products (28.8%) and corticosteroids for systemic
use (41.1%). Follow-up data was already collected for 1298
patients, so results from wastage due to patients’ non-adherence,
regardless of packs inadequacy, will also be presented. CON-
CLUSIONS: The wastage associated with the size of medicines
packs prescribed is signiﬁcant in particular for some therapeutic
groups. Total wastage is expected to be higher taking into con-
sideration patients’ non-compliance.
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BENEFIT INCIDENCE ANALYSIS BEFORE AND AFTER
UNIVERSAL COVERAGE IN THAILAND
Prakongsai P,Tangcharoensathien V
International Health Policy Program—Thailand, Nonthaburi,Thailand
OBJECTIVES: To investigate changes in the distribution of gov-
ernment health resources towards different socio-economic
groups of Thais after implementation of the policy on universal
coverage (UC). Effectiveness of the UC policy in improving
equity in access to health services and distribution of government
health resources were also assessed. METHODS: Four main
steps of beneﬁt incidence analysis were employed in order to
analyze the distribution of the net government health subsidies.
The analysis of beneﬁt incidence between different approaches:
using household income and asset index to classify individual
socio-economic status; and using aggregated and regional gov-
ernment unit subsidies. Data sources comprise the national
household surveys on health service use of individuals in 2001
(before UC) and 2003 (after UC), unit government subsidies for
public and private providers in 2001 & 2003. RESULTS: The
concentration indices of ambulatory services at health centres,
district hospitals, and provincial hospitals were more pro-poor
after UC (changing from −0.29, −0.26, and −0.04 in 2001 to 
−0.36, −0.32, and −0.08 in 2003, respectively). The concentra-
tion indices of hospitalization increased their negative values
from −0.079 in 2001 to −0.121 in 2003. The distribution of net
government health subsidies was more pro−poor after UC with
a change in the concentration indices from −0.044 to −0.123.
There was not a signiﬁcant difference in the distribution of 
government health subsidies when income and asset index were
used as means testing, or using aggregated unit subsidies, com-
pared to regional variations. CONCLUSIONS: The UC policy
